Leukemic Phase of ALCL

Leukemic Phase of ALK+ Anaplastic Lymphoma in Real-life Practice: Experience of a University Clinical Hematology Laboratory

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04908059

Acronym

LEUK-ALCL

Enrollment

Registered

2021-06-01

Start date

2021-01-27

Completion date

2021-07-13

Last updated

2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaplastic Lymphoma

Keywords

Anaplastic lymphoma, Leukemic phase

Brief summary

Collecting data about the rare leukemic presentation of anaplastic lymphoma to study the characteristics of patients with leukemic phase of ALCL

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

9 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients presenting a leukemic phase of anaplastic lymphoma

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
A retrospective study of the diagnostic description of the leukemic phases of anaplastic lymphoma in real life	Files analysed retrospectively from January 01, 2020 to December 31, 2020 will be examined]

Countries

France

Contacts

Primary ContactLaurent MAUVIEUX, MD, PhD

laurent.mauvieux@chru-strasbourg.fr33 3 88 12 75 27

Backup ContactSaïd CHAYER, PhD, HDR

said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results